Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Return on Capital Employed (2016 - 2021)

Historic Return on Capital Employed for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Q4 2021 value amounting to 0.36%.

  • Avadel Pharmaceuticals' Return on Capital Employed fell 3800.0% to 0.36% in Q4 2021 from the same period last year, while for Dec 2021 it was 0.36%, marking a year-over-year decrease of 3800.0%. This contributed to the annual value of 0.33% for FY2021, which is 3600.0% down from last year.
  • Latest data reveals that Avadel Pharmaceuticals reported Return on Capital Employed of 0.36% as of Q4 2021, which was down 3800.0% from 0.3% recorded in Q3 2021.
  • In the past 5 years, Avadel Pharmaceuticals' Return on Capital Employed registered a high of 0.65% during Q3 2017, and its lowest value of 0.75% during Q2 2019.
  • In the last 5 years, Avadel Pharmaceuticals' Return on Capital Employed had a median value of 0.08% in 2018 and averaged 0.1%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first plummeted by -10500bps in 2018, then soared by 8400bps in 2020.
  • Over the past 5 years, Avadel Pharmaceuticals' Return on Capital Employed (Quarter) stood at 0.5% in 2017, then crashed by -210bps to 0.55% in 2018, then soared by 63bps to 0.2% in 2019, then surged by 109bps to 0.02% in 2020, then crashed by -2009bps to 0.36% in 2021.
  • Its Return on Capital Employed stands at 0.36% for Q4 2021, versus 0.3% for Q3 2021 and 0.24% for Q2 2021.